Deep learning-based drug screening for the discovery of potential therapeutic agents for Alzheimer's disease
Alzheimer's disease (AD) is gradually increasing in prevalence and the complexity of its pathogenesis has led to a lengthy process of developing therapeutic drugs with limited success. Faced with this challenge, we proposed using a state-of-the-art drug screening algorithm to identify potential...
Saved in:
Main Authors: | Tong Wu (Author), Ruimei Lin (Author), Pengdi Cui (Author), Jie Yong (Author), Heshui Yu (Author), Zheng Li (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Therapeutic potential of snake venom: Toxin distribution and opportunities in deep learning for novel drug discovery
by: Anas Bedraoui, et al.
Published: (2024) -
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer's Disease
by: Sarah Beggiato, et al.
Published: (2019) -
Evaluation of bumetanide as a potential therapeutic agent for Alzheimer's disease
by: Ben Boyarko, et al.
Published: (2023) -
Experimental modelling of Alzheimer's disease for therapeutic screening
by: Laura Blaikie, et al.
Published: (2022) -
Alzheimer's Disease: Drug Discovery
Published: (2020)